---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-000243"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2026-01-02T23:59:59+00:00"
generated_at: "2026-05-16T11:46:45.657768+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NWBO shareholders OK share increase to 2.6B, elect Pat Sarma

## Summary
- Authorized common shares increased from 1.7B to 2.6B; 89.65% of votes cast in favor.
- Over 77% of total voting power represented at annual meeting; quorum present.
- Pat Sarma elected as Class II director for three-year term with 81.1% of votes for.
- Ratified Cherry Bekaert LLP as independent auditor for FY2025 (93.76% for).
- Advisory vote on executive compensation approved with 77.23% of votes for.

## SEC filing metadata
- accession: 0001104659-26-000243
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2026-01-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465926000243/0001104659-26-000243-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465926000243/tm261685d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-000243
- JSON: https://secwatch.observer/filing/0001104659-26-000243.json
- Plain text: https://secwatch.observer/filing/0001104659-26-000243.txt

## Source-grounded claims
- claim_id: 0b12a9652ebcab2dff3c0b673b855438ba1cee48
  claim: NORTHWEST BIOTHERAPEUTICS INC: Increased authorized shares of common stock from 1,700,000,000 to 2,600,000,000 (effective 2025-12-30).
  evidence_excerpt: On December 30, 2025, the Company filed a Certificate of Amendment of its Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of the State of Delaware, which effected an increase in the Company’s authorized shares of common stock, from 1,700,000,000 to 2.600,000,000, par value $0.001 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1072379/000110465926000243/0001104659-26-000243-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.